Shortage of foreign drugs becomes the main problem of a pharmaceutical market Russian Federation in 2023

Experts called the main problem of the pharmaceutical market Russian Federation forthcoming year. "In 2023 Russian Federation will need more than ever many pharmaceutical products which would be replaced with that were delivered by large international pharmaceutical companies, left from the market" — the head of the Russian pharmaceutical companies "declared Farm Ade" Metov Azamat in conversation from Federal state unitary enterprise RAMI "RIA Novosti". According to him, it is a question of monoclonal antibodies, bio and chemical preparations, anticarcinogenic therapy, vaccines and other preparations. The expert noted that for closing of these requirements pharmaceutical producers will have to put emphasis...